<img alt="" src="https://secure.perk0mean.com/171547.png" style="display:none;">
CALL US +44 (0)1462 440 084 | +1 919-882-2016 | Contact | Submit RFI

Getting your clinical data requirements right,
first time, all the time

As a Leading Global Data-Focused Clinical Research Organization we are always #CodedToCare. This is our commitment to bringing medicines to patients faster through the provision of high quality data capture, analysis and reporting.

Submit an RFI      Live Webinar

Our Clinical Data Services:

statistics2.png

Biostatistics

Statistical services have always been a key component of Quanticate's services as part of our heritage.

Learn More>

Programming.pngStatistical Programming

As an integral function within Biometrics, Quanticate programmers have supported clinical trials since 1994.

Learn more>

Data_Management.pngClinical Data Management

Quanticate's CDM team offer CRF design, database design, edit checks, discrepancy management, and coding of AEs and medications.

Learn More>

Medical_Writing_for_homepahe.png

Medical Writing

Our medical writing services include clinical and regulatory writing.

Learn More>

Pharmacovigilance.pngPharmacovigilance

Quanticate offers a range of PV services throughout all phases of clinical trials as well as post-marketing.

Learn more>

Consultancy.pngConsultancy

Having so many experts within Quanticate provides us with the opportunity to provide real value to our clients.

Learn more>

Quanticate_Home Page IMG2

The three steps to a faster drug approval

icon_Submit RFISubmit an RFI >

  • Secure a meeting with our experts

  • Put in place a CDA/NDA

  • Specify your needs and requests 

  • Our specialist will guide you to a tailored outsourcing solution
icon_parnterPart of your team >

  • Kick-off meeting and selection of the preferred approach

  • Quanticate resources assigned to your team according to your preferred resource model

  • Focused on customer satisfaction and quality via our 'Coded To Care' Mantra
icon_complianceYour Drug is Approved!

  • All your data integrity and quality has improved

  • Your regulatory submission was a success

  • You improved study efficiency and reduced timelines

  • A new partnership is formed, and we are committed to improving your clinical data for future studies

What Our Customers Are Saying

Fertility Biotech logo 02

Julian Jenkins

CEO - Fertility Biotech AG

“Quanticate is one of the best CROs I have ever worked with in the past and they are really outstanding at biometrics. Quanticate have supported us with the analysis of a large phase 3 study, an integrated summary of efficacy and interactions with regulatory authorities. We have a great relationship with Quanticate at Fertility Biotech; they’re helpful and take the time to understand our needs. I would recommend them to anyone looking for any biometrics support."

KinetAssist02

Charlie Brindley

Director - KinetAssist

"Quanticate is a clinical data expert and as a consultant I find they are easy to deal with, making my life much easier. Good communication and expectations management mean that we have built a good relationship over time which enables me to provide an excellent service to my clients in a timely and effective manner.”

Speak to a member of our Business Development team about our clinical and safety data services

Request   Consultation

The Latest From Our Resources

Design of Phase 1 Oncology Studies

Design of Phase I Oncology Studies  

This white paper explores the use of Model-based Designs in Phase I Oncology Studies, providing advantages and explanation for the slow uptake of this design method. 

Real World Data in Gene Therapy

Real-World Data in Gene Therapy Trials  

This Whitepaper gives examples of how real-world data helps the development of gene therapies by considering the contribution of conducting adequate and controlled studies.

Designing and Analyzing Hemophilia Clinical Trials

Designing and Analyzing Hemophilia Clinical Trials

This Whitepaper focuses on designing and analyzing clinical trials for the treatment of Hemophilia A, exploring particularly the small population it effects, the slow recruitment rate and many other factors that should be considered.

Browse All Resources

Latest Blog

Latest News

Our Next Events

Quality Data and Data Fitness in a Regulatory Submission

                        New call-to-action           New call-to-action

Fabien2

“We make sure our global footprint ensures efficiency, resulting in over 93% of our customers providing repeat business each year.”

“Our solutions save our clients in excess of 30% of the costs that they spent prior to developing a relationship with Quanticate.”

CDISC_Provider.png